Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | NARROWPEAK | Mar 01, 2024 | ||||||
GSE215773 |
Elucidation of the effects of tonic TCR stimulation and tissue environments of the chromatin status of naive CD4 T (TN) cells
|
18 |
|
Takashi Sekiya | Mar 01, 2024 | |||
GSE230526 |
Aberrant non-canonical NF-κB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma
|
90 | Yinghui Li | Mar 01, 2024 | ||||
GSE220508 |
ChIP-seq analysis for endogenous FOXO1 in human endothelial cells
|
3 | Shunsuke Kamei | Mar 01, 2024 | ||||
GSE220509 |
Transcriptional regulation by FOXO1 in Human endothelial cells
|
11 | Shunsuke Kamei | Mar 01, 2024 | ||||
GSE227704 |
The nucleoskeleton protein NuMA maintains local chromatin architecture partially through promoting linker histone H1’ binding to chromatin and nucleosome stacking [Cut & Tag]
|
7 | Wenxue Zhao | Mar 01, 2024 | ||||
GSE227940 |
The nucleoskeleton protein NuMA maintains local chromatin architecture partially through promoting linker histone H1’ binding to chromatin and nucleosome stacking [ATAC-Seq]
|
6 |
|
Wenxue Zhao | Mar 01, 2024 | |||
GSE227941 |
The nucleoskeleton protein NuMA maintains local chromatin architecture partially through promoting linker histone H1’ binding to chromatin and nucleosome stacking
|
21 | Wenxue Zhao | Mar 01, 2024 | ||||
GSE250359 |
PRDM3/16 Regulate Chromatin Accessibility Required for NKX2-1 Mediated Alveolar Epithelial Differentiations and Function [ATAC-seq]
|
11 |
|
Yan Xu | Mar 01, 2024 | |||
GSE250366 |
PRDM3/16 Regulate Chromatin Accessibility Required for NKX2-1 Mediated Alveolar Epithelial Differentiations and Function
|
46 | Yan Xu | Mar 01, 2024 | ||||
GSE252935 |
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or Menin inhibitor (ChIP-Seq)
|
12 |
|
Xiaoping Su | Mar 01, 2024 | |||
GSE252938 |
BRG1/BRM inhibitor targets AML stem cells and exerts superior preclinical efficacy combined with BET or Menin inhibitor
|
34 | Xiaoping Su | Mar 01, 2024 | ||||
GSE183998 |
Genomic analyses of H1 cells induced by FOXO1
|
5 |
|
Liu Yasong | Mar 01, 2024 | |||
GSE184139 |
Chromatin Landscape Analysis of H1 cells with different temperature.
|
4 |
|
Liu Yasong | Mar 01, 2024 | |||
GSE185152 |
The RANBP2/Importin-7-FOXO1 axis provides superior cold protection to aid islet transplantation
|
89 | Liu Yasong | Mar 01, 2024 | ||||
GSE198940 |
Comparative cofactor screens reveal the influence of transactivation domains and core promoters on the mechanisms of transcription [ChIP-seq]
|
13 |
|
Charles C Bell | Mar 01, 2024 | |||
GSE198944 |
Comparative cofactor screens reveal the influence of transactivation domains and core promoters on the mechanisms of transcription.
|
165 | Charles C Bell | Mar 01, 2024 | ||||
GSE202680 |
Identifying transcriptional targets of ONECUT3 by ChIP-seq
|
6 |
|
Hongyan Tong | Mar 01, 2024 | |||
GSE202694 |
The transcriptional factor ONECUT3 is a driver and therapeutic target for complex karyotype MDS
|
12 |
|
Hongyan Tong | Mar 01, 2024 | |||
GSE230277 |
Aberrant non-canonical NF-κB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma [ATAC-seq]
|
10 |
|
Yinghui Li | Mar 01, 2024 | |||
GSE230466 |
Aberrant non-canonical NF-κB signalling reprograms the epigenome landscape to drive oncogenic transcriptomes in multiple myeloma [ChIP-seq]
|
61 |
|
Yinghui Li | Mar 01, 2024 |